Loading...
Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects
Recently, the use of nebulized antibiotics in the intensive care unit, in particular amikacin, has been the subject of much discussion, owing to unconvincing results from the latest randomized clinical trials. Here, we examine and reappraise the evidence in favor and against this therapeutic strateg...
Saved in:
| Published in: | Crit Care |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6297966/ https://ncbi.nlm.nih.gov/pubmed/30558658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-018-1958-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|